Transgene Biotek Ltd

BSE :526139 NSE :- Sector : Healthc..
4.25
Change: 0.19(4.68%)
52 week Low
3.87
52 week High
11.34
Day low
3.87
Day high
4.26
Prev Close
4.06
Open
4.10
6M return
-53.75%
1Y return
-59.10%
MCap(Rs. in Cr.)
30.76
Total Volume
27,714
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
NM
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
-0.03
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
2.97
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
100%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
155.56%

Sales Industry Avg
26.35%

PAT
-93.65%

PAT Industry Avg
4.42%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales0.080.060.050.050.23
Gross Profit-0.07-0.050.22-0.25-0.56
Operating Profit00000
Profit Before Tax-0.09-0.070.20-0.27-0.66
Tax00000
Profit After Tax-0.09-0.070.20-0.27-0.66
Growth in 3 years

Total Asset Growth
-3.47%

Total Liabilities growth
-3.47%

Reserves Change
11.42%

Mar 2024
( in Cr.)
Mar 2023
( in Cr.)
Mar 2022
( in Cr.)
Mar 2021
( in Cr.)
Mar 2020
( in Cr.)
Share Capital75.7775.7775.7775.7775.77
Reserves And Surplus-65.06-64.40-58.39-53.53-43.10
Investments0.100.100.1000
Total Debt129.40128.68127.76127.25126.43
Total Liabilities140.11140.05145.14149.49159.10
Total Assets140.12140.06145.15149.50159.11
No data available


Relative to Sensex rtn in 3 year
-31.56%

Relative to Nifty rtn in 3 year
-34.55%



1 Year (%)2 Year (%)3 Year (%)
Transgene Biotek-596421
Bse Sensex42531
Nifty 5042933

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Transgene Biotek
4.25
Change: 0.19 (4.68%)
1 Year return
-59.10%
Risk (Std Dev)
0.18%
PE Ratio
NM
MCap( in Cr.)
30.76
One Global Serv
297.95
Change: -6.05 (-1.99%)
1 Year return
297.11%
Risk (Std Dev)
0.35%
PE Ratio
18.81
MCap( in Cr.)
215.84
M E T S
192.50
Change: 7.25 (3.91%)
1 Year return
46.72%
Risk (Std Dev)
0.22%
PE Ratio
17.13691
MCap( in Cr.)
102.08
Choksi Laborator
132.30
Change: -2.65 (-1.96%)
1 Year return
166.41%
Risk (Std Dev)
0.30%
PE Ratio
73.34
MCap( in Cr.)
94.00
Aspira Pathlab
63.34
Change: 1.24 (2.00%)
1 Year return
85.64%
Risk (Std Dev)
0.21%
PE Ratio
75.73171
MCap( in Cr.)
63.92
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 40,904.70 with a Loss of -59.10%

News

Stay tuned to the latest developments and happenings in the company.

Transgene Biotek reports consolidated net loss of Rs 0.09 crore in the December 2024 quarter

Net Loss of Transgene Biotek reported to Rs 0.09 crore in the quarter ended December 2024 as against net loss of Rs 0.12 crore during the previous qua....

24 Jan 2025 13:41

Transgene Biotek declare Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live News</b....

17 Jan 2025 11:58

Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter

Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024 as against net loss of Rs 0.13 crore during the previous qu....

12 Nov 2024 13:48

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News</b....

05 Nov 2024 12:01

Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter

Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against net loss of Rs 0.13 crore during the previous quart....

12 Aug 2024 11:58

Transgene Biotek to hold board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 10 August 2024.Powered by Capital Market - Live News....

20 Jul 2024 12:06

View More
Subscribe for our
newsletter
Open Account Now